Gynecologic Cancer

A novel three-drug combination bested standard-of-care regimens for patients with human papillomavirus-related cancers, according to phase 2 study results.

This is the only first-line trial to show benefit with immuno-oncology plus chemotherapy in patients with advanced or recurrent endometrial cancer.

In my cousin Barbara’s salon, a group of fellow Black women helped boost my confidence as I shaved my head after being diagnosed with cancer.

After being diagnosed with cancer, an amazing posse of loved ones formed around me, but perhaps nobody was as helpful as my loving husband.

From a uterine cancer survivor camping out in front of a store to meet the Astros’ Jose Altuve to Michael Armand Hammer’s death from cancer, here’s what’s happening in the cancer space this week.

One expert said that the FDA approval of the antibody-drug conjugate Elahere represents a new treatment option for patients with folate receptor alpha-positive, platinum resistant ovarian cancer.

The FDA approved Elahere for patients with pretreated, folate receptor alpha (FRα)-positive platinum-resistant gynecological cancers

I have many things to be thankful for regarding my ovarian cancer: from my recent CT scan results to an excellent oncology team.

The thought of hosting family for a week in the middle of cancer treatment made me anxious, so I set a boundary — and felt much better after the fact.

When comparing my experiences with those who came before me, I’m happy to realize that cancer treatments have gotten better and there are more Black leaders in the medical community.

Women who face menopause after a cancer diagnosis may be able to manage their symptoms without relying on estrogen-based therapies, although discussing this with a cancer team will help patients find what’s best for them.

I knew my family was close, but it wasn’t until my mom was diagnosed that I realized how bonded we truly were.

Vaginal cancer is amongst the rarest of gynecologic cancer, it is important those patients with a rare cancer advocate for themselves and find doctors who are experts in treating it.

From Blink-182’s bassist Mark Hoppus discussing his cancer experience in an upcoming book to Bruce Sutter, a Hall-of-Fame pitcher and Cy Young winner, dying of the disease, here’s what’s happening in the cancer space this week.

NC410 plus Keytruda will be studied in a phase 1b/2 trial for patients with certain solid cancers that either did not respond to or have not been treated with an immunotherapy agent.

The truth is I stagger back and forth between the two camps — tell it like it is or walking on sunshine. It depends on the day, my treatment regimen, the lab or scan results, the losses and the gains.

My healthy body was hijacked by an enemy (ovarian cancer) launching my continuous fight against the disease.

From “Chicago Med” actress Marlyne Barrett announcing her gynecologic cancer diagnosis to a New York City-based news team walking in honor of their former news director who died of glioblastoma, a form of brain and spinal cord cancer, here’s what’s happening in the cancer space this week.

The FDA’s approval of Vegzelma was based on data that demonstrated the biosimilar elicited comparable safety and efficacy to Avastin in several studies.

The OnPrime trial will investigate if adding Olvi-Vec, a modified virus, to chemotherapy and Avastin will improve outcomes for pretreated platinum-resistant or refractory ovarian cancer.

Maintenance therapy helps deter undetectable cancer that may exist after initial treatment.

Treatment with Libtayo may improve survival over a 30-month period with no new side effects in patients with recurrent or metastatic cervical cancer, opening the doors for an immunotherapy option for these patients.

Lenvima plus Keytruda improved survival outcomes for patients with pretreated advanced endometrial cancer, according to recent clinical trial data.

Rubraca improved progression-free survival in patients with BRCA1/2-mutant, platinum-sensitive, relapsed ovarian cancer, according to findings from the ARIEL4 clinical trial.

Cervical cancer survivor Ginny Marable heard about a story of a fellow cervical cancer survivor, Tamika Felder, not being able to preserve her fertility. The story moved Marable so much that she and her husband donated their embryos to Felder.